EUVIMEDEUVIMED entdecken
Crossref

Human umbilical cord mesenchymal stem cell‐derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting Hedgehog/SMO signaling

Ke Zhang iD, Shuo Zheng iD, Jiasheng Wu iD, Jing He iD, Yu Ouyang iD, Chunchun Ao iD, Ruibo Lang iD, Yijia Jiang iD, Yifan Yang iD, Huan Xiao iD, Yu Li iD, Mao Li iD und 3 weitere

The FASEB Journal · 15.04.2024 · 38 (7)

DOI: 10.1096/fj.202302324r ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 04.04.2024. Verfasst von Ke Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Wuhan University School of Basic Medical Sciences, Wuhan, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Exosomes, Mesenchymal Stem Cells, Diabetes Mellitus. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Wuhan Municipal Science and Technology Bureau, Ministry of Science and Technology of the people's republic of China, Science and Technology Innovation Bureau, Zengcheng Economic and Technological Development Zone, Guangzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN) is the leading cause of end‐stage renal disease globally. Currently, there are no effective drugs for the treatment of DN. Although several studies have reported the therapeutic potential of mesenchymal stem cells, the underlying mechanisms remain largely unknown. Here, we report that both human umbilical cord MSCs (UC‐MSCs) and UC‐MSC‐derived exosomes (UC‐MSC‐exo) attenuate kidney damage, and inhibit epithelial‐mesenchymal transition (EMT) and renal fibrosis in streptozotocin‐induced DN rats. Strikingly, the Hedgehog receptor, smoothened (SMO), was significantly upregulated in the kidney tissues of DN patients and rats, and positively correlated with EMT and renal fibrosis. UC‐MSC and UC‐MSC‐exo treatment resulted in decrease of SMO expression. In vitro co‐culture experiments revealed that UC‐MSC‐exo reduced EMT of tubular epithelial cells through inhibiting Hedgehog/SMO pathway. Collectively, UC‐MSCs inhibit EMT and renal fibrosis by delivering exosomes and targeting Hedgehog/SMO signaling, suggesting that UC‐MSCs and their exosomes are novel anti‐fibrotic therapeutics for treating DN.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesExosomesMesenchymal Stem CellsDiabetes MellitusHumansRatsAnimalsSmoothened ReceptorHedgehog ProteinsFibrosisUmbilical Cord

Stichwörter der Autor:innen

Hedgehog signalingdiabetic nephropathyepithelial‐mesenchymal transitionexosomeshuman umbilical cord mesenchymal stem cellskidney fibrosis

Substanzen

Smoothened ReceptorHedgehog ProteinsSMO protein, human

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Wuhan University School of Basic Medical Sciences, Wuhan, China.
  • R&D Center, Wuhan Hamilton Biotechnology Co., Ltd, Wuhan, China.
  • The 2nd Affiliated Hospital of Harbin Medical University, Harbin, China.
  • School of Life Science, Hubei University, Wuhan, China.
  • Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China.
  • Department of Physiology, Wuhan University School of Basic Medical Sciences, Wuhan, China.

ORCID-Profile: Ke Zhang, Shuo Zheng, Jiasheng Wu, Jing He, Yu Ouyang, Chunchun Ao, Ruibo Lang, Yijia Jiang, Yifan Yang, Huan Xiao, Yu Li, Mao Li, Huiming Wang, Changyong Li, Dongcheng Wu

Förderung

  • Wuhan Municipal Science and Technology Bureau
  • Ministry of Science and Technology of the people's republic of China
  • Science and Technology Innovation Bureau, Zengcheng Economic and Technological Development Zone, Guangzhou
  • Department of Science and Technology of Hubei Province
  • Wuhan East Lake New Technology Development Zone Science and Technology Innovation Bureau and new Economic Development Bureau

Zitieren

APA

Zhang, K., Zheng, S., Wu, J., He, J., Ouyang, Y., Ao, C., Lang, R., Jiang, Y., Yang, Y., Xiao, H., Li, Y., Li, M., Wang, H., Li, C., & Wu, D. (2024). Human umbilical cord mesenchymal stem cell‐derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting Hedgehog/SMO signaling. The FASEB Journal, 38(7). https://doi.org/10.1096/fj.202302324r

Vancouver

Zhang K, Zheng S, Wu J, He J, Ouyang Y, Ao C, et al. Human umbilical cord mesenchymal stem cell‐derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting Hedgehog/SMO signaling. The FASEB Journal. 2024;38(7). doi:10.1096/fj.202302324r

BibTeX
@article{Zhang2024,
  author = {Zhang, Ke and Zheng, Shuo and Wu, Jiasheng and He, Jing and Ouyang, Yu and Ao, Chunchun and Lang, Ruibo and Jiang, Yijia and Yang, Yifan and Xiao, Huan and Li, Yu and Li, Mao and Wang, Huiming and Li, Changyong and Wu, Dongcheng},
  title = {Human umbilical cord mesenchymal stem cell‐derived exosomes ameliorate renal fibrosis in diabetic nephropathy by targeting Hedgehog/SMO signaling},
  journal = {The FASEB Journal},
  year = {2024},
  volume = {38},
  number = {7},
  doi = {10.1096/fj.202302324r}
}
Kostenlos starten →